Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
DPH2 Monoclonal Antibody (OTI2B12), TrueMAB™, OriGene

Mouse Monoclonal Antibody
Supplier: OriGene TA504856S


Description
DPH2 Monoclonal antibody specifically detects DPH2 in Human samples. It is validated for Flow Cytometry, Immunohistochemistry (Paraffin), Western BlotSpecifications
DPH2 | |
Monoclonal | |
1 mg/mL | |
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide | |
Q9BQC3 | |
Mouse | |
Affinity chromatography | |
RUO | |
1802 | |
-20° C, Avoid Freeze/Thaw Cycles | |
IgG2b |
Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot | |
OTI2B12 | |
Unconjugated | |
DPH2 | |
2-(3-amino-3-carboxypropyl)histidine synthase subunit 2; 9130020C19Rik; AI467389; diphthamide biosynthesis 2; diphthamide biosynthesis protein 2; diphthamide biosynthesis protein 2 homolog-like 2; diphthamide biosynthesis-like protein 2; Diphtheria toxin resistance protein 2; diptheria toxin resistance protein required for diphthamide biosynthesis (Saccharomyces)-like 1; diptheria toxin resistance protein required for diphthamide biosynthesis (Saccharomyces)-like 2; diptheria toxin resistance protein required for diphthamide biosynthesis-like 2; DPH2; DPH2 homolog; DPH2 homolog (S. cerevisiae); DPH2L2; DPH2-like 2; EGK_00671; MmDph2; S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2; S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase DPH2 | |
Full length human recombinant protein of human DPH2 produced in HEK293T cell. | |
30 μL | |
Primary | |
Human | |
Liquid |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction